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Cueing Effects on the BG
A Role of the Basal Ganglia
in Movement: The Effect of Precues
on Discrete Bi-directional Movements
in Parkinson’s Disease
Andrew M. Johnson, Philip A. Vernon, Quincy J. Almeida,
Linda L. Grantier, and Mandar S. Jog
The effect of a precue on improving movement initiation (i.e., reaction time;
RT) is well understood, whereas its influence on movement execution (i.e.,
movement time; MT) has rarely been examined. The current study investi-
gated the influence of a directional precue (i.e., left vs. right) on the RT and
MT of simple and discrete bi-directional movements in a large sample of
Parkinson’s disease patients and healthy control participants. Both patients
and controls were tested twice, with testing sessions separated by 2 hours.
Patients were tested first following an overnight levodopa withdrawal and
again after they had taken their medication. Both patients and controls dem-
onstrated a significant RT improvement when information was provided in
advance. MT in both healthy participants and medicated patients was, how-
ever, slower with the provision of advance information, while unmedicated
patients showed no significant MT effects. These results suggest that while
the basal ganglia may not be involved in motor program selection, they may
dynamically modulate movement execution.
Key Words: ■
Parkinson’s disease (PD) is a progressive neurological disorder that affects the
ability of older adults to execute movements (Marsden & Obeso, 1994). Aside
from the importance of achieving greater understanding of a disorder that is con-
sidered to be the most common of the movement disorders (Water, 1998), compar-
ing movement control in individuals with Parkinson’s disease to that of a healthy
control population can provide insight into the contribution of the basal ganglia to
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movement. Furthermore, manipulation of dopaminergic status may offer an op-
portunity to evaluate the extent to which individuals are able to “return to normal”
through treatment.
Simple reaction time (RT) has repeatedly been demonstrated to show sig-
nificant deficits in PD populations, and these deficits have been shown to be sen-
sitive to dopaminergic medications (Brown, Jahanshahi, & Marsden, 1993; Coo-
per, Sagar, Tidswell, & Jordan, 1994; Daum & Quinn, 1991; Gauntlett-Gilbert &
Brown, 1998; Hallett, 1990; Henderson & Goodrich, 1993; Jahanshahi, Brown, &
Marsden, 1992a, 1992b; Jordan, Sagar, & Cooper, 1992; Mayeux, Stern, Sano,
Cote, & Williams, 1987; Mazzucchi et al., 1993; Montgomery & Nuessen, 1990;
Muller et al., 1999; Zimmermann, Sprengelmeyer, Fimm, & Wallesch, 1992).
Simple RT allows one to examine deficits in the selection of a motor program (and
the effect of medication in alleviating this slowness) but provides no information
about the effect of task complexity on movement execution, or the cognitive pro-
cesses implicated in PD bradykinesia or bradyphrenia. To answer these types of
questions, a choice RT task may be employed. Although it is generally accepted
that choice RT also shows an overall impairment in PD (Bloxham, Mindel, &
Frith, 1984; Evarts, Teravainen, & Calne, 1981; Filipovic et al., 1997; Gauntlett-
Gilbert & Brown, 1998; Girotti et al., 1986; Harrington & Haaland, 1998; Pull-
man, Watts, Juncos, & Sanes, 1990; Stelmach, Worringham, & Strand, 1986;
Willingham, Koroshetz, Treadwell, & Bennett, 1995; Worringham & Stelmach,
1990), specific conditions under which PD patients demonstrate impairment are
still the subject of some debate. One such condition is the provision of a motor
precue. In healthy adults, reaction time improves with the provision of a precue
that provides relevant information about a movement, even if the precue is pro-
vided before the actual movement event (Rosenbaum, 1980). Interestingly, these
same directional precues had no significant effect on MT (Rosenbaum, 1980).
Authors as early as Donders (1969) have suggested that provision of ad-
vance information in a way that removes the selection phase of a task will invari-
ably reduce RT in healthy participants. Evarts et al. (1981), however, may have
provided the first evidence of a PD motor pre-programming deficit, using a
precueing paradigm to establish the effect of advance information on RT. They
demonstrated (albeit without the use of inferential statistical techniques) that al-
though PD patients show no significant reaction time improvement with the avail-
ability of advance information, controls become significantly faster with the pro-
vision of a precue. A motor pre-programming deficit in PD is purported, therefore,
to represent an inability to utilize informational cues to “pre-program” movement
(Bloxham et al., 1984; Evarts et al., 1981; Filipovic et al., 1997; Girotti et al.,
1986; Harrington & Haaland, 1998; Pullman et al., 1990; Stelmach et al., 1986;
Willingham et al., 1995; Worringham & Stelmach, 1990). Gauntlett-Gilbert and
Brown (1998) provide a particularly comprehensive quantitative review of the
motor pre-programming hypothesis.
Motor pre-programming deficits are not universally considered to be respon-
sible for choice reaction time deficits in Parkinsonian patients. Some researchers
suggest that Parkinsonian patients and normal controls use different strategies for
approaching reaction time experiments. (I.e., Parkinsonian patients recognize that
they may have accuracy problems on the tasks, and hence are deliberately slow in
all phases of movement; Brown et al., 1993; Henderson & Goodrich, 1993.) Other
researchers propose that there are no specific programming deficits attributable to
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basal ganglia dysfunction, but rather that these apparent deficits are the result of
non-specific brain damage (Jahanshahi et al., 1992a). It has also been suggested
that programming deficits are a result of impaired processing during stimulus per-
ception, which leads to slower motor initiation (Kutukcu, Marks, Goodin, &
Aminoff, 1999). This controversy suggests that further research is needed, using
large patient samples, adequately matched controls, and a consideration of the
effects of medication.
Recent models of the basal ganglia are potentially relevant to the motor pre-
programming hypothesis. A number of existing theoretical models propose that
the basal ganglia may modulate cortical output that guides the execution of move-
ment (Almeida, Wishart, & Lee, 2002, in press; J. Contreras-Vidal & Stelmach,
1995; J.L. Contreras-Vidal, 1999; Humphries & Gurney, 2002). In this situation, it
may be possible that the presentation of relevant precues may engage the basal
ganglia during movement. A behavioral approach to the investigation of basal gan-
glia involvement in the processing of advance information is, therefore, important.
The purpose of the present study is to test the effect of both advance information
and medication on a sample of PD patients and well-matched controls.
It is expected that the provision of advance information will reduce the time
required for participants to select a motor program, shortening RT in healthy con-
trols. In contrast, the motor pre-programming hypothesis predicts that the RT of
PD patients will not improve with the provision of advance information. Further-
more, as the amount of available dopamine increases (as with the administration
of levodopa), the basal ganglia will become more active in the modulation of move-
ment, and the additional striatal-thalamo inputs to the primary motor areas of the
cortex will increase MT.
Method
Participants
Forty patients with Parkinson’s disease (27 men and 13 women) with an average
age of 65.02 (SD = 8.84; range, 38–78 years), and 40 controls (13 men and 27
women) with an average age of 62.13 (SD = 9.59; range, 36–86 years) participated
in the study. No significant differences between group ages were found. Baseline
cognitive ability was matched between the two groups by estimating their Wechsler
Adult Intelligence Scale (WAIS) full scale IQ (FSIQ) with the National Adult Read-
ing Test (NART; Nelson, 1982). FSIQ within the PD group ranged from 91.36 to
125.22 (M = 110.63, SD = 7.92) and was not significantly different from the mean
FSIQ within the control group, which ranged from 88.05 to 124.40 (M = 111.51,
SD = 8.03). Handedness was defined as the hand with which the participant wrote
most comfortably, and all but 7 participants (3 patients and 4 controls) were right
handed. During the course of testing, patients were assessed by an experienced
clinician (using the Unified Parkinson’s Disease Rating Scale) to determine the
severity of their symptoms (Fahn, Elton, & Members of the UPDRS Development
Committee, 1987). Severity of illness for patients in this sample ranged from mild
to moderate, both “on” and “off” medication. In the non-medicated stage of test-
ing, motor scores on the Unified Parkinson’s Disease Rating Scale (UPDRS) ranged
from 4.50 to 43.50 (M = 24.49, SD = 9.79), and in the medicated stage of testing (2
hours after medication), scores on the UPDRS ranged from 1.50 to 40.50 (M =
17.16, SD = 8.99). The difference between “off” and “on” scores was significant,
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t(39) = 7.10, p < .0001; 2 = 0.564, suggesting that the condition labels (off medi-
cation and on medication) presented herein are accurate reflections of the clinical
symptoms of the patients.
The inclusion criteria for patients were: (a) clinically definite Parkinsonism
with bradykinesia and at least one of rigidity, tremor, or postural instability; (b)
absence of dementia (Mini-Mental Status score of >27/30)1; (c) predictable, docu-
mented response to immediate release L-dopa therapy; and (d) no other concomi-
tant motor disability impairing movement. The exclusion criteria were: (a) signifi-
cant cognitive impairment; (b) unpredictable response to L-dopa; (c) prior
neurological disorder; and (d) current treatment with anticholinergic medication.
Patients were allowed to be on other anti-Parkinsonian medications (including
dopamine agonists) in addition to their L-dopa (except anticholinergics).
Apparatus
The tasks used in the study required subjects to respond to a visual stimulus, pre-
sented on a computer screen (a white apple symbol on a black background). All
responses were completed using an external, color-coded, three-button response
console (red, yellow, and green from left to right) connected to an Apple Macintosh
LC475 personal computer with a 15-in. color monitor. Participants were instructed
to hold down the “home key” (the yellow button in the middle of the console) with
the index finger of their dominant hand. Both tasks required the participant to
move the finger depressing the home key to one of the remaining two buttons. The
computer recorded the time between presentation of the visual stimuli and lifting
of the participant’s finger from the home key (RT; reaction time), and the time
taken to move his/her finger to a response key (MT; movement time). All partici-
pants were instructed to respond as quickly as possible but were told that they
must not lift their finger from the home key (the yellow button) until they knew the
direction in which they would be moving. The timing card in the response console
was capable of 1 ms accuracy.
Both tasks started with an instruction to watch a fixation point (asterisk) in
the center of the computer screen, while depressing the home key. For the uncued
task, participants were not given any advance information concerning the location
of the upcoming stimulus. For the cued task, an arrow appeared in place of the
fixation point (i.e., in the center of the screen) for a period of 2 s, immediately
following the disappearance of the fixation point, and correctly cued the location
of the upcoming stimulus on all trials. The visual stimulus to which the subject
responded was presented on the right or left side of the monitor, at a random inter-
val (between 500 and 1500 ms) following the fixation point (uncued) or the arrow
(cued). Each task consisted of 10 practice and 40 experimental trials, with the
fastest and slowest reaction times discarded to form composite RT and MT scores.
Both tasks were coded in PsyScope version 1.2.4, a well-validated platform for
recording reaction times (Cohen, MacWhinney, Flatt, & Provost, 1993)2.
Procedure
All patients involved in the study were asked to remain drug-free overnight, and to
skip their morning anti-Parkinsonian medications. The average off-drug duration
was 10.81 ± 2.52 hours. To avoid any confounding effects resulting from different
levels of caffeine intake among participants, all participants were asked to have a
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normal caffeine-free breakfast prior to testing. None of the participants reported
any acute physiological conditions that may have precluded them from putting
forth their best effort during the testing session.
All patients were tested at 0800 and retested at 1130 (after taking their medi-
cation), while controls were tested at 0930 and retested at 1300. This allows for a
2-hour time delay between testing patients in an “off” and “on” condition, as rec-
ommended by Gauntlett-Gilbert and Brown (1998). On average, therefore, pa-
tients may be considered to be optimally medicated at the time of the second evalu-
ation, based on the results of infusion studies that suggest that peak “on” time is
experienced at 146 ± 30 min for patients experiencing stable medication effects
(Juncos, Mouradian, Fabrini, & Chase, 1995).
The review board for health sciences research involving human subjects at
the University of Western Ontario approved the procedure and apparatus for this
study, and informed consent was obtained from all participants.
Results
Two analyses of variance (ANOVA) were conducted, using the RT and MT scores
for the two tests as dependent variables. Clinical Group (PD patients vs. controls)
was used as a between-subjects variable, and both Time Period (“pre-dopamine”
and “post-dopamine” in patients, “time 1” and “time 2” in controls) and Cueing
Level (i.e., cued and uncued) were used as within-subjects variables. The motor
pre-programming hypothesis was further tested using four paired t tests on the RT
scores—one for each participant group at each time period of the study. Means and
standard deviations for the response time data are presented in Table 1.
Reaction Time Results
The main effect of clinical group was significant, F1,78 = 22.37, p < .0001, with PD
patients demonstrating a significantly slower RT than controls. The main effect of
Table 1 Means (and Standard Deviations) for RT and MT, Across Cueing
and Medication Conditions, for PD Patients and Controls
Subject PD Patients Controls
Cued RT OFF 402.34 (102.46) Time 1 336.45 (49.26)
ON 379.25 (61.06) Time 2 336.37 (51.89)
Uncued RT OFF 413.95 (95.40) Time 1 346.03 (49.75)
ON 415.52 (84.32) Time 2 356.62 (41.79)
Cued MT OFF 359.58 (124.00) Time 1 228.07 (78.41)
ON 320.39 (112.19) Time 2 225.06 (86.05)
Uncued MT OFF 359.18 (151.51) Time 1 192.41 (64.20)
ON 299.81 (119.52) Time 2 195.38 (85.56)
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cueing was also significant, F1,78 = 13.486, p < .0001, revealing that cued RT was
significantly faster than uncued RT. None of the interactions with clinical group
were, however, significant, suggesting that PD patients were not differentially
impaired by the provision of advance information, and further suggesting that
dopaminergic intervention was not effective for improving RT. A graphical com-
parison of patient and control results across the cueing levels is presented in Figure 1.
Due to the fact that within-cell effect sizes were small for the RT task, results
were also investigated outside the three-factor ANOVA, using four paired t tests
(comparing cued and uncued RT)—one for each participant group at each time
period of the study. Multiple comparison bias was controlled using a Bonferroni
adjustment to the experiment-wise alpha. (I.e., the experiment-wise alpha was ad-
justed to be 0.05/4 = 0.0125.) Neither the patient group nor the control group
demonstrated a significant difference between cued and uncued RT at time 1 (“off-
medication”). At time 2, however (“on-medication”), cued RT was significantly
faster than uncued RT for both patients, t(39) = 4.095, p < .0001, and controls,
t(39) = 3.286, p < .0020.
Movement Time Results
The main effect of clinical group was significant, F1,78 = 36.96, p < .0001, with PD
patients demonstrating a significantly slower MT than healthy control participants.
The main effect of cueing was also significant, F1,78 = 21.342, p < .0001, and cued
MT was significantly slower than uncued MT. The two-way interaction of clinical
group and cueing level was significant, F1,78 = 5.63, p < .020, with PD patients
demonstrating less impairment from the provision of advance information than
controls. Furthermore, the two-way interaction of Clinical Group and Time Period
was significant, F1,78 = 7.18, p < .01, with patients demonstrating greater improve-
ment in their movement time between testing sessions than controls (i.e., a signifi-
cant medication effect). Finally, the three-way interaction of Clinical Group, Time
Figure 1 — Reaction times: patient versus control. This figure shows changes in reaction
time across patients and controls, using both Cueing Level and Drug Treatment Phase
as factors.
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Period, and Cueing Level was significant, F1,78 = 3.92, p < .05, with post hoc analysis
demonstrating that both cued and uncued movement times improved when “on”
dopaminergic medications. Interestingly, similar to controls, the cued movement
time was now slower among PD patients in the “on” state than uncued movement
time. A graphical comparison of patient and control results across the cueing lev-
els is presented in Figure 2.
Discussion
The results of the reaction time testing in this study suggest that the provision of
directional advance information (a directional precue) reduced the time required
to respond to a stimulus. Contrary to previous initiation-of-movement studies, RT
improved for both patients and controls. These results do not agree with previ-
ously published motor pre-programming findings (Bloxham et al., 1984; Evarts et
al., 1981; Filipovic et al., 1997; Gauntlett-Gilbert & Brown, 1998; Harrington &
Haaland, 1991, 1998; Stelmach et al., 1986; Willingham et al., 1995), which dem-
onstrate a PD reaction time deficit unrelated to availability of a movement precue.
The present study involved substantially more participants than any previous study
(for a review, see Gauntlett-Gilbert & Brown, 1998), and so the power of the com-
parison is correspondingly higher (allowing for the detection of smaller differ-
ences between the cued and uncued tasks).
The present results are the first explicit empirical demonstration of slower
movement time in healthy controls following the provision of directional advance
information (precue). Rosenbaum (1980), in one of the original examinations of
precue effects on MT, showed that directional precues only influence reaction time
but not movement time, although this may be due to the small n size in this early
Figure 2 — Movement times: patient versus control. This figure shows changes in
movement time across patients and controls, using both Cueing Level and Drug
Treatment Phase as factors.
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study (n = 10). The power of the present finding is reinforced by the fact that
individuals with PD more closely approximate the movement time difference be-
tween cued and uncued tasks (demonstrated by control participants) when dopam-
ine levels are brought closer to normal levels through dopamine replacement medi-
cations (i.e., as the basal ganglia approach normalcy). A recent study reported a
seemingly opposite effect, in that a moving visual cue (a ball that rolled to a target
grasping location) was able to speed up movement time, while a static visual cue
(a ball sitting stationary at the target grasping location) showed no MT improve-
ment (Majsak, Kaminski, Gentile, & Flanagan, 1998). However, if this study is
considered from a precueing perspective, availability of advance information was
also manipulated in this study. It should be noted that the static visual cue acts as a
precue (providing advance information about target location) and thereby slows
movement time. In the “moving visual cue” condition, on the other hand, advance
information about the target location is unavailable and cannot, therefore, be in-
corporated into execution of the movement (i.e., movement time is not slowed).
From a precueing perspective, the present results would actually be predicted from
the research of Majsak et al. (1998).
The inclusion of a parkinsonian population allows us to evaluate current
models purporting a role of the basal ganglia in the initiation and control of move-
ment. It is well known that the basal ganglia receive a variety of cortical inputs
during the planning and execution of movement. Among these inputs, involve-
ment of the premotor (PM), supplementary motor area (SMA), and prefrontal cor-
tex is thought to be noteworthy. Experimental evidence supports the involvement
of the SMA in the internal planning of movement, while PM neurons guide re-
sponses to external stimuli (Nolte, 1999) such as a precue. In their projections to
the basal ganglia, these higher cortical centers are proposed to provide neural feed-
back (via the thalamus) to motor areas for maintenance of a motor program (Almeida
et al., in press; J. Contreras-Vidal & Stelmach, 1995; J.L. Contreras-Vidal, 1999).
In the context of our experiment, since movement characteristics were kept con-
stant (i.e., distance, type of response required) through a number of repetitions, we
propose that a consistent and repetitive pattern of neural activation would be likely
for these types of simple movements. This notion is supported in recent literature
describing neuronal activation patterns in tasks that involve changes from con-
trolled to more automatic processing (Jansma, Ramsey, Slagter, & Kahn, 2001). It
is therefore hypothesized that established motor programs are selected and ex-
ecuted rapidly, through cortico-cortical connections. The basal ganglia output to
the cortex in this situation serves as a comparator and is not used if the active
motor program does not require it.
From this perspective, the availability of a directional precue (as the primary
independent variable) in our experiment may be considered useful in evaluating
additional processing done by the basal ganglia during movement. Our results
demonstrate that a directional precue can improve reaction time in both healthy
and basal ganglia-disordered populations, which would suggest that the basal gan-
glia are not directly involved in using advance information to select a motor pro-
gram. However, it is probable that a directional precue may be processed by the
basal ganglia during movement execution, thereby slowing movement. When the
basal ganglia are unable to actively participate in the modulation of movement
during execution (as in the “off” medication condition), the precue does not slow
movement execution.
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Although every effort was made to evaluate the effects of dopaminergic
medications on the motor activities assessed within the present study, the present
design is limited by its reliance on a test-retest paradigm in which “on” periods
always follow “off” periods, as this confounds medication and practice effects.
Future studies may wish to examine the effects directional precues within de novo
patient populations (i.e., patients that have not been treated with dopaminergic
medication). This type of medication control paradigm would allow for an assess-
ment of the extent to which chronic levodopa treatment affects the basal ganglia.
It should also be emphasized that the present study involved the use of simple
motor tasks, and so some caution should be exercised in the interpretation of these
results. Furthermore, there is some indication within the literature that the basal
ganglia may be differentially involved in the mediation of precues involving di-
rection and amplitude (Jones, Phillips, Bradshaw, Iansek, & Bradshaw, 1993; Pull-
man, Watts, Juncos, Chase, & Sanes, 1988; Pullman et al., 1990). Interestingly,
Pullman et al. (1988, 1990) argues that the effect of advance information may be
unique to the provision of directional information, while Jones (1993) suggests
that neither component demonstrates a specific impairment. Given this lack of
consensus, future studies should attempt to control medication state in studies that
examine movement time on more complex tasks, with different methods of cue-
ing. It would also be interesting to expand on the “uncued” condition by evaluat-
ing the effect of providing a movement precue that contains no information (i.e., a
precue that must be processed, but which contains no useful information). As the
present study proposes an information processing explanation for the effects of
precues on movement time, it would be relevant to exert greater control over the
presentation of information.
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